X
EXAS

Xponance’s Exact Sciences EXAS Stock Holding History

Xponance’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,865
Closed -$1.1M – 1707
2025
Q4 		$1.1M Buy
10,865
+602
+6% +$48.3K 0.01% 667
2025
Q3 		$561K Sell
10,263
-224
-2% -$11.2K ﹤0.01% 924
2025
Q2 		$557K Sell
10,487
-14,485
-58% -$736K ﹤0.01% 910
2025
Q1 		$1.08M Buy
24,972
+959
+4% +$48.6K 0.01% 665
2024
Q4 		$1.35M Buy
24,013
+2,264
+10% +$141K 0.01% 622
2024
Q3 		$1.48M Buy
21,749
+173
+0.8% +$9.76K 0.01% 595
2024
Q2 		$912K Buy
21,576
+799
+4% +$44K 0.01% 700
2024
Q1 		$1.43M Buy
20,777
+8,372
+67% +$530K 0.02% 618
2023
Q4 		$918K Sell
12,405
-668
-5% -$43.8K 0.01% 701
2023
Q3 		$892K Buy
13,073
+235
+2% +$19.9K 0.01% 682
2023
Q2 		$1.21M Buy
12,838
+3,303
+35% +$258K 0.02% 604
2023
Q1 		$647K Buy
9,535
+33
+0.3% +$2.12K 0.01% 822
2022
Q4 		$470K Buy
9,502
+2,740
+41% +$112K 0.01% 916
2022
Q3 		$220K Buy
6,762
+177
+3% +$7.3K ﹤0.01% 1070
2022
Q2 		$259K Sell
6,585
-11,927
-64% -$638K 0.01% 1045
2022
Q1 		$1.29M Buy
18,512
+339
+2% +$24.8K 0.02% 508
2021
Q4 		$1.41M Buy
18,173
+6
+0% +$530 0.02% 488
2021
Q3 		$1.73M Sell
18,167
-425
-2% -$44.9K 0.03% 377
2021
Q2 		$2.31M Buy
18,592
+5,110
+38% +$610K 0.04% 333
2021
Q1 		$1.78M Buy
13,482
+150
+1% +$20.5K 0.04% 341
2020
Q4 		$1.77M Sell
13,332
-163
-1% -$19.7K 0.04% 334
2020
Q3 		$1.38M Buy
13,495
+57
+0.4% +$4.92K 0.03% 351
2020
Q2 		$1.17M Buy
+13,438
New +$1.07M 0.03% 355

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Xponance's EXAS Position: Q1 2026 in Review

Xponance sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 10,865 shares — an estimated $1.1M sold.

Xponance first reported a position in EXAS in Q2 2020 and held it in 23 quarters. The position peaked at $2.31M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Xponance reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Xponance sold 10,865 Exact Sciences shares in Q1 2026, an estimated $1.1M.
  • Xponance first reported a position in Exact Sciences in Q2 2020 and held it in 23 quarters.
  • Xponance's Exact Sciences position peaked at $2.31M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.